Literature DB >> 22640762

Managing co-occurring substance use and pain disorders.

Karen Miotto1, Aaron Kaufman, Alexander Kong, Grace Jun, Jeffrey Schwartz.   

Abstract

The safest pain treatment strategy for an individual at risk or recovering from addiction is a nonopioid and benzodiazepine-free approach. If an opioid treatment is necessary, the extent of the risk can be stratified by the use of a biopsychosocial assessment and opioid screening tools. Individuals at high risk should have the greatest amount of structure and monitoring. A written informed consent and treatment agreement can provide a framework for the patient and the patient’s family, as well as the clinician. The structure of treatment should specify only that one prescribing physician will write a limited supply of opioids, without refills, until the analgesic efficacy, adverse events, and goals for functional restoration can be assessed. An additional recommendation is that prescriptions should be filled at the same pharmacy with no refill by phone or opportunity for replacement because of loss, damage, or stolen medications. Additionally, random urine drug screens and PDMP reports obtained will help determine if the patient is taking other substances, as well as monitor the patient’s medication use patterns. It is important to assess for risk factors in treating chronic pain with opioids; clinicians need to have a realistic appreciation of the resources available to them and the types of patients that can be managed in their practice. Chronic pain treatment with opioids should not be undertaken in patients who are currently addicted to illicit substances or alcohol. With the support of family and friends, ideally the patient can be motivated to participate in an intensive substance abuse treatment. In patients without an immediate risk, precautionary steps should be taken when prescribing opioids. Clinicians and patients need to review the risk factors for opioid-related problems including younger age, benzodiazepine use, and comorbid conditions such as depression, anxiety, and heavy smoking. Both the provider and the patient need a personal investment in the treatment plan and protocol to increase the safety of opioid treatment. New medications and treatment monitoring are being developed to provide maximal relief for the patient while protecting the public health. The optimal ingredients for safe opioid treatment include a strong provider-patient relationship and clinician training in the assessment and treatment of addiction and pain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22640762     DOI: 10.1016/j.psc.2012.03.006

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  10 in total

Review 1.  How to assess a new patient for a multidisciplinary chronic pain rehabilitation program: a review article.

Authors:  Adham Malaty; Josephine Sabharwal; Lesley Smallwood Lirette; Gassan Chaiban; Hazem Eissa; Reda Tolba
Journal:  Ochsner J       Date:  2014

2.  Opioid Prescribing for the Treatment of Acute Pain in Children on Hospital Discharge.

Authors:  Constance L Monitto; Aaron Hsu; Shuna Gao; Paul T Vozzo; Paul S Park; Deborah Roter; Gayane Yenokyan; Elizabeth D White; Deepa Kattail; Amy E Edgeworth; Kelly J Vasquenza; Sara E Atwater; Joanne E Shay; Jessica A George; Barbara A Vickers; Sabine Kost-Byerly; Benjamin H Lee; Myron Yaster
Journal:  Anesth Analg       Date:  2017-12       Impact factor: 5.108

3.  Rules and values: a coordinated regulatory and educational approach to the public health crises of chronic pain and addiction.

Authors:  Joanna G Katzman; George D Comerci; Michael Landen; Larry Loring; Steven M Jenkusky; Sanjeev Arora; Summers Kalishman; Lisa Marr; Chris Camarata; Daniel Duhigg; Jennifer Dillow; Eugene Koshkin; Denise E Taylor; Cynthia M A Geppert
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

Review 4.  Fibromyalgia comorbid with anxiety disorders and depression: combined medical and psychological treatment.

Authors:  Marcio Bernik; Thiago P A Sampaio; Lucas Gandarela
Journal:  Curr Pain Headache Rep       Date:  2013-09

Review 5.  The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients Through a Written Document.

Authors:  Barth Wilsey; J Hampton Atkinson; Thomas D Marcotte; Igor Grant
Journal:  Clin J Pain       Date:  2015-12       Impact factor: 3.442

Review 6.  Pain Control in the Presence of Drug Addiction.

Authors:  Nalini Vadivelu; Leandro Lumermann; Richard Zhu; Gopal Kodumudi; Amir O Elhassan; Alan David Kaye
Journal:  Curr Pain Headache Rep       Date:  2016-05

7.  Self-management of pain among people who inject drugs in Vancouver.

Authors:  Pauline Voon; Cody Callon; Paul Nguyen; Sabina Dobrer; Julio Montaner; Evan Wood; Thomas Kerr
Journal:  Pain Manag       Date:  2014-01

8.  Benzodiazepine use in patients with chronic pain in an interdisciplinary pain rehabilitation program.

Authors:  Julie L Cunningham; Julia R Craner; Michele M Evans; W Michael Hooten
Journal:  J Pain Res       Date:  2017-02-09       Impact factor: 3.133

9.  A Predictive Algorithm to Detect Opioid Use Disorder: What Is the Utility in a Primary Care Setting?

Authors:  Chee Lee; Maneesh Sharma; Svetlana Kantorovich; Ashley Brenton
Journal:  Health Serv Res Manag Epidemiol       Date:  2018-01-21

10.  A prospective, longitudinal study to evaluate the clinical utility of a predictive algorithm that detects risk of opioid use disorder.

Authors:  Ashley Brenton; Chee Lee; Katrina Lewis; Maneesh Sharma; Svetlana Kantorovich; Gregory A Smith; Brian Meshkin
Journal:  J Pain Res       Date:  2018-01-05       Impact factor: 3.133

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.